Predictors of Treatment With Tecovirimat and Hospitalization Among People With Mpox and HIV
Background: Thousands of mpox cases have been reported in the US since 2022, disproportionately affecting people with HIV (PWH), but epidemiologic data on mpox among PWH are limited. We examined demographic and clinical characteristics of PWH with mpox across the US in the Center for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) cohort.…